SuttonBrook Capital Management »

Orexigen Therapeutics shares owned by SuttonBrook Capital Management

Quarter-by-quarter ownership of Orexigen Therapeutics shares owned by SuttonBrook Capital Management from 13F filings

Historical chart of SuttonBrook Capital Management investment in Orexigen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orexigen Therapeutics held by SuttonBrook Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orexigen Therapeutics by SuttonBrook Capital Management

Quarter filed Position value Share count Share price at filing
2012-09-30 $1.1M 200k 5.71
2012-03-31 $750k 500k 1.50

More positions owned by SuttonBrook Capital Management

Hertz Global Holdings
MeadWestva
Vivus
Mbia (MBI)
Chemtura Corporation
Howard Hughes
Comverse Technology
Orexigen Therapeutics
Yahoo!
Anadarko Petroleum Corporation
Spdr S&p 500 Etf (SPY)
iShares MSCI Emerging Markets Indx (EEM)

View all positions for SuttonBrook Capital Management

Top funds holding Orexigen Therapeutics

Huntington National Bank

View all funds holding Orexigen Therapeutics